Brief: Bellicum reports Q3 net loss per share $0.66
09/11/2016 21:05
Nov 9 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O -
* Quarterly net loss per share $0.66
* Q3 earnings per share view $-0.63 -- Thomson Reuters
I/B/E/S
* Bellicum reports third quarter 2016 financial results
Source text for Eikon: ID:nBw5xj0SHa
Further company coverage: BLCM.O
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview